LA HR320 | 2024 | Regular Session

Status

Completed Legislative Action
Spectrum: Partisan Bill (Democrat 1-0)
Status: Passed on June 3 2024 - 100% progression
Action: 2024-06-04 - Taken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
Text: Latest bill text (Enrolled) [PDF]

Summary

Recognizes gene editing as a significant advancement in the treatment of sickle cell disease

Tracking Information

Register now for our free OneVote public service or GAITS Pro trial account and you can begin tracking this and other legislation, all driven by the real-time data of the LegiScan API. Providing tools allowing you to research pending legislation, stay informed with email alerts, content feeds, and share dynamic reports. Use our new PolitiCorps to join with friends and collegaues to monitor & discuss bills through the process.

Monitor Legislation or view this same bill number from multiple sessions or take advantage of our national legislative search.

Title

Recognizes gene editing as a significant advancement in the treatment of sickle cell disease

Sponsors


Roll Calls

2024-06-03 - House - House Vote on HR 320 FINAL CONSIDERATION (#1766) (Y: 94 N: 0 NV: 0 Abs: 11) [PASS]

History

DateChamberAction
2024-06-04HouseTaken by the Clerk of the House and presented to the Secretary of State in accordance with the Rules of the House.
2024-06-03HouseEnrolled and signed by the Speaker of the House.
2024-06-03HouseRead by title, amended, roll called, yeas 94, nays 0. The resolution was adopted.
2024-06-03HouseCalled from the calendar.
2024-05-31HouseRead by title, returned to the calendar.
2024-05-30HouseScheduled for floor debate on 05/31/2024.
2024-05-30HouseRead by title, rules suspended, passed to 3rd reading.

Subjects


Louisiana State Sources


Bill Comments

feedback